(Q43786691)

26 November 2017

PI 3-kinase, mTOR, protein synthesis and cancer (English)

1 reference

26 November 2017

1

1 reference

26 November 2017

1 November 2001

1 reference

Trends in Molecular Medicine

26 November 2017

1 reference

26 November 2017

7

1 reference

26 November 2017

482-484

1 reference

26 November 2017

11

1 reference

Oncogenic kinase signalling

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

TOR, a central controller of cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

PIK3CA is implicated as an oncogene in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

eIF4E expression in tumors: its possible role in progression of malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

Constitutive activation of S6 kinase by deletion of amino-terminal autoinhibitory and rapamycin sensitivity domains

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902161-X

7 January 2021

10.1016/S1471-4914(01)02161-X

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11689313